Medacta International obtained approval under the CE Mark for a lateralized glenosphere component, expanding its range of reverse shoulder replacement options.
The device features a more lateralized centre of rotation vs. the standard glenosphere presently marketed with the Medacta Shoulder. The lateralization can support an improved range of motion, as well as a reduced risk of scapular notching.
Medacta’s modular shoulder system, pictured below, includes a range of sizes, adjustable offset and anatomic and reverse configurations. It is compatible with the company’s CT-based MyShoulder 3D preoperative planning solution, with patient-specific humeral and glenoid guides.
Source: Medacta
Medacta International obtained approval under the CE Mark for a lateralized glenosphere component, expanding its range of reverse shoulder replacement options.
The device features a more lateralized centre of rotation vs. the standard glenosphere presently marketed with the Medacta Shoulder. The lateralization can support an improved range...
Medacta International obtained approval under the CE Mark for a lateralized glenosphere component, expanding its range of reverse shoulder replacement options.
The device features a more lateralized centre of rotation vs. the standard glenosphere presently marketed with the Medacta Shoulder. The lateralization can support an improved range of motion, as well as a reduced risk of scapular notching.
Medacta’s modular shoulder system, pictured below, includes a range of sizes, adjustable offset and anatomic and reverse configurations. It is compatible with the company’s CT-based MyShoulder 3D preoperative planning solution, with patient-specific humeral and glenoid guides.
Source: Medacta
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
